Andreas Brunschweiger

Dr. Andreas Brunschweiger


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2014 in Nature Chemical Biology
Verified
Journal Article
Closed access
JIJochen Imig
Jochen Imig
ABAndreas Brunschweiger
Andreas Brunschweiger
ABAnneke Brümmer
Anneke Brümmer
BGBoris Guennewig
Boris Guennewig
NMNitish Mittal
Nitish Mittal
JHJonathan Hall
Jonathan Hall

28 January 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
HSHazem Salamon
Hazem Salamon
MŠMateja Klika Škopić
Mateja Klika Škopić
KJKathrin Jung
Kathrin Jung
OBOlivia Bugain
Olivia Bugain
ABAndreas Brunschweiger
Andreas Brunschweiger

1 May 2020 in Tetrahedron Letters
Verified
Journal Article
Closed access
KGKatharina Götte
Katharina Götte
SCSilvia Chines
Silvia Chines
ABAndreas Brunschweiger
Andreas Brunschweiger

7 June 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MŠMateja Klika Škopić
Mateja Klika Škopić
KGKatharina Götte
Katharina Götte
CGChristian Gramse
Christian Gramse
MDMarvin Dieter
Marvin Dieter
SPSabrina Pospich
Sabrina Pospich
ABAndreas Brunschweiger
Andreas Brunschweiger

14 June 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
VKVerena B. K. Kunig
Verena B. K. Kunig
MPMarco Potowski
Marco Potowski
MAMohammad Akbarzadeh
Mohammad Akbarzadeh
MŠMateja Klika Škopić
Mateja Klika Škopić
DSDenise dos Santos Smith
Denise dos Santos Smith
ABAndreas Brunschweiger
Andreas Brunschweiger
DNA‐encoded combinatorial synthesis provides efficient and dense coverage of chemical space around privileged molecular structures. The indole side chain of tryptophan plays a prominent role in key, or “hot spot”, regions of protein–protein interactions. A DNA‐encoded combinatorial peptoid library was designed based on the Ugi four‐component reaction by employing tryptophan‐mimetic indole side chains to probe the surface of target proteins. Several peptoids were synthesized on a chemically stable hexathymidine adapter oligonucleotide “hexT”, encoded by DNA sequences, and substituted by azide‐alkyne cycloaddition to yield a library of 8112 molecules. Selection experiments for the tumor‐relevant proteins MDM2 and TEAD4 yielded MDM2 binders and a novel class of TEAD‐YAP interaction inhibitors that perturbed the expression of a gene under the control of these Hippo pathway effectors.

28 February 2020 in Cells
Verified
Journal Article
Open access
PDF file
Donat KögelDonat Kögel
Donat Kögel
Benedikt LinderBenedikt Linder
Benedikt Linder
ABAndreas Brunschweiger
Andreas Brunschweiger
SCSilvia Chines
Silvia Chines
Christian BehlChristian Behl
Christian Behl
BAG3, a multifunctional HSP70 co-chaperone and anti-apoptotic protein that interacts with the ATPase domain of HSP70 through its C-terminal BAG domain plays a key physiological role in cellular proteostasis. The HSP70/BAG3 complex determines the levels of a large number of selective client proteins by regulating their turnover via the two major protein degradation pathways, i.e. proteasomal degradation and macroautophagy. On the one hand, BAG3 competes with BAG1 for binding to HSP70, thereby preventing the proteasomal degradation of its client proteins. By functionally interacting with HSP70 and LC3, BAG3 also delivers polyubiquitinated proteins to the autophagy pathway. BAG3 exerts a number of key physiological functions, including an involvement in cellular stress responses, proteostasis, cell death regulation, development, and cytoskeletal dynamics. Conversely, aberrant BAG3 function/expression has pathophysiological relevance correlated to cardiomyopathies, neurodegeneration, and cancer. Evidence obtained in recent years underscores the fact that BAG3 drives several key hallmarks of cancer, including cell adhesion, metastasis, angiogenesis, enhanced autophagic activity, and apoptosis inhibition. This review provides a state-of-the-art overview on the role of BAG3 in stress and therapy resistance of cancer, with a particular focus on BAG3-dependent modulation of apoptotic signaling and autophagic/lysosomal activity.